MONDAY, Oct. 7, 2024 — A simple blood test may help doctors decide the best way to treat a man with advanced prostate cancer.
A phase 3 clinical trial has shown that circulating tumor cell (CTC) counts can predict which men are likely to respond…
You may also like
Choosing the Right Rehab for Yourself or a Loved One
Hope for New Test, Treatment for Endometriosis
IV Fluid Plant in Florida Remains Functional After...
2 Million Fisher-Price Infant Swings Recalled After 5...
All Those Head Spins By Breakdancers Could Be Harming...
Unprotected Sex Boosts Mpox Danger for Gay Men as...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.